These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 12453895)
21. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Erickson JC; Hollopeter G; Palmiter RD Science; 1996 Dec; 274(5293):1704-7. PubMed ID: 8939859 [TBL] [Abstract][Full Text] [Related]
29. Role of the Y5 neuropeptide Y receptor in feeding and obesity. Marsh DJ; Hollopeter G; Kafer KE; Palmiter RD Nat Med; 1998 Jun; 4(6):718-21. PubMed ID: 9623983 [TBL] [Abstract][Full Text] [Related]
30. Effects of subcutaneous leptin injections on hypothalamic gene profiles in lean and ob/ob mice. Duan J; Choi YH; Hartzell D; Della-Fera MA; Hamrick M; Baile CA Obesity (Silver Spring); 2007 Nov; 15(11):2624-33. PubMed ID: 18070753 [TBL] [Abstract][Full Text] [Related]
31. Synergistic attenuation of obesity by Y2- and Y4-receptor double knockout in ob/ob mice. Lee NJ; Enriquez RF; Boey D; Lin S; Slack K; Baldock PA; Herzog H; Sainsbury A Nutrition; 2008 Sep; 24(9):892-9. PubMed ID: 18662863 [TBL] [Abstract][Full Text] [Related]
32. Effect of Agouti-related protein in regulation of the hypothalamic-pituitary-thyroid axis in the melanocortin 4 receptor knockout mouse. Fekete C; Marks DL; Sarkar S; Emerson CH; Rand WM; Cone RD; Lechan RM Endocrinology; 2004 Nov; 145(11):4816-21. PubMed ID: 15256492 [TBL] [Abstract][Full Text] [Related]
33. Neuropeptide Y deficiency attenuates responses to fasting and high-fat diet in obesity-prone mice. Patel HR; Qi Y; Hawkins EJ; Hileman SM; Elmquist JK; Imai Y; Ahima RS Diabetes; 2006 Nov; 55(11):3091-8. PubMed ID: 17065347 [TBL] [Abstract][Full Text] [Related]
34. VGF ablation blocks the development of hyperinsulinemia and hyperglycemia in several mouse models of obesity. Watson E; Hahm S; Mizuno TM; Windsor J; Montgomery C; Scherer PE; Mobbs CV; Salton SR Endocrinology; 2005 Dec; 146(12):5151-63. PubMed ID: 16141392 [TBL] [Abstract][Full Text] [Related]
35. Differential regulation of agouti-related protein and neuropeptide Y in hypothalamic neurons following a stressful event. Kas MJ; Bruijnzeel AW; Haanstra JR; Wiegant VM; Adan RA J Mol Endocrinol; 2005 Aug; 35(1):159-64. PubMed ID: 16087729 [TBL] [Abstract][Full Text] [Related]
36. Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats. Havel PJ; Hahn TM; Sindelar DK; Baskin DG; Dallman MF; Weigle DS; Schwartz MW Diabetes; 2000 Feb; 49(2):244-52. PubMed ID: 10868941 [TBL] [Abstract][Full Text] [Related]
37. Hypothalamic gene expression in sheep for cocaine- and amphetamine-regulated transcript, pro-opiomelanocortin, neuropeptide Y, agouti-related peptide and leptin receptor and responses to negative energy balance. Adam CL; Archer ZA; Findlay PA; Thomas L; Marie M Neuroendocrinology; 2002 Apr; 75(4):250-6. PubMed ID: 11979055 [TBL] [Abstract][Full Text] [Related]
38. Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice. Bina KG; Cincotta AH Neuroendocrinology; 2000 Jan; 71(1):68-78. PubMed ID: 10644901 [TBL] [Abstract][Full Text] [Related]
39. Fasting regulates hypothalamic neuropeptide Y, agouti-related peptide, and proopiomelanocortin in diabetic mice independent of changes in leptin or insulin. Mizuno TM; Makimura H; Silverstein J; Roberts JL; Lopingco T; Mobbs CV Endocrinology; 1999 Oct; 140(10):4551-7. PubMed ID: 10499510 [TBL] [Abstract][Full Text] [Related]